News

MOH Welcomes Clinical Trials On Products Containing Cannabis Extract For Medical Use

KUALA LUMPUR, July 28 (Bernama) — The Ministry of Health (MOH) welcomes applications to conduct clinical trials on products containing cannabis extract for medical purposes as no such clinical trials are being carried out in the country so far, said Deputy Health Minister Datuk Dr Noor Azmi Ghazali.

He said the Dangerous Drugs Act 1952, the Poisons Act 1952 and the Sale of Drugs Act 1952 have already allowed the production of cannabis extract to be supplied, imported, sold, used for medical purposes, research, or clinical trials for medical purposes subject to the requirements provided by the acts.

He was responding to a question from Syed Saddiq Syed Abdul Rahman (MUDA-Muar) who wanted MOH to state the latest status on the legalisation and use of medical cannabis in Malaysia.

Elaborating, Dr Azmi said companies that have adequate scientific proof of the effectiveness of products containing cannabis extract for medical purposes can submit an application to register the products to Drug Control Authority under the ministry.

In addition, he said companies with medical cannabis products that have been approved abroad, can apply to have their products registered and marketed in Malaysia.

“The MOH does not reject studies on the effectiveness of medical cannabis, it is time we follow the steps of 40 countries that have used it to treat diseases including cancer, depression, and epilepsy, we are ready to look at this,” he said.

Meanwhile, on the proposal to separate interpretations of cannabis, medical cannabis, and hemp from a legal aspect, he said, the matter would depend on the findings of the main committee on the development of the cannabis and ketum industry for medical purposes set up by the ministry and tasked to study and formulate the direction of the industry’s development.

“Therefore the need to amend the Dangerous Drugs Act 1952 in connection with the control of cannabis and hemp including creating separate interpretations for cannabis and hemp depends on the Cabinet’s decision after reviewing the committee’s findings, taking into account the legal, socio-cultural, health, economy, Shariah law aspects and so on,” he added.

Sources: BERNAMA

Adib Mohd

Recent Posts

Casio x The Sandbox: G-SHOCK Is Now in the Metaverse

Brace yourself, your favorite tough-as-nails watch just got a futuristic makeover. Casio is teaming up… Read More

40 minutes ago

Pandora’s “Colour Pop” Collection Is Serving Summer Energy in Every Sparkle

Looking to brighten up your style this summer? Pandora's latest “Colour Pop” collection is bringing… Read More

1 hour ago

Zoom into Brilliance, HUAWEI Pura 80 Series Arrives in Malaysia with Unmatched Camera Power and Striking Design

HUAWEI Malaysia has officially unveiled its next-generation flagship lineup, the HUAWEI Pura 80 Series, setting a… Read More

1 day ago

PayNet Joins MIT CSAIL’s FinTechAI Initiative as Sole Malaysian Member, Pioneering Ethical AI in Finance

Payments Network Malaysia Sdn Bhd (PayNet) has been named the sole Malaysian founding member of… Read More

1 day ago

NakNak’s Bold Bulgogi Series: Big Flavours, Korean Vibes & A Side of Curly Fries

Homegrown quick service restaurant brand NakNak is turning up the flavour this season with the… Read More

2 days ago

Eco-Shop Ushers in Merdeka Spirit with Nationwide “Satu Senyuman, Seribu Makna” Campaign

Eco-Shop, Malaysia’s Leading Ultra Affordable Household Retailer, is calling on Malaysians to rediscover the beauty… Read More

2 days ago

This website uses cookies.